Alex Brecher

Losing weight quickly is the point of the operation. It is also, inconveniently, the strongest known trigger for gallstone formation. This is one of the few complications where the thing causing the problem is the thing working correctly, which makes it worth understanding rather than worrying about. Why rapid weight loss causes stonesBile is a solution of cholesterol, bile salts and phospholipids, held in balance. Rapid weight loss disturbs that balance in more than one way at once. Fat tissue breaking down releases a large amount of cholesterol into circulation, and the liver excretes it into bile. Bile becomes supersaturated with cholesterol, meaning it holds more than it can keep dissolved. At the same time, eating far less fat means far less stimulation of the gallbladder, so it contracts less often and empties less completely. Bile sits in the gallbladder longer. Supersaturated bile plus stasis is the standard recipe for cholesterol stones. The clinical literature describes this as rapid weight loss increasing the lithogenicity of bile. How often it happensThe reported range is wide, and it depends heavily on whether the study looked for stones with ultrasound in everyone or only counted people who developed symptoms. After Roux-en-Y gastric bypass, reported incidence of gallstones ranges from 7 percent to 53 percent, with most figures clustering around 30 percent.A study of patients after sleeve gastrectomy, using ultrasound over a mean follow-up of about 20.6 months, found gallstones in 36.9 percent. Of those with stones, 31.8 percent went on to have symptoms requiring laparoscopic cholecystectomy. The mean interval from surgery to stone detection was around 210 days.A broad clinical reference puts the rate at 10 percent to 25 percent in the context of rapid weight loss generally.Two things are worth pulling out of that. First, most gallstones after bariatric surgery are found because someone looked, not because they caused trouble. Second, only a minority of people who form stones ever become symptomatic. A systematic review of cholecystectomy in bariatric patients found the incidence of biliary complications to be about 5.54 cases per 1,000 patient-years, which is a low number. The riskiest window is roughly the first 6 to 18 months, when weight is coming off fastest. What symptomatic gallstones feel likeBiliary colic. Steady, severe pain in the upper right abdomen or just below the breastbone, often radiating to the back or the right shoulder blade. It builds over minutes, plateaus for anywhere from 30 minutes to several hours, then fades. It is classically triggered by a fatty meal and it often wakes people at night.Nausea and vomiting with the pain.Milder presentations, including epigastric discomfort or nausea that is easy to mistake for ordinary post-operative food intolerance.Escalations that need urgent attention: Cholecystitis, where the gallbladder becomes inflamed and infected. Pain lasting more than a few hours, fever, and marked tenderness.Choledocholithiasis and cholangitis, where a stone lodges in the bile duct. Yellowing of the skin or eyes, dark urine, pale stools, fever with rigors.Gallstone pancreatitis. Severe pain boring through to the back, persistent vomiting.One thing worth knowing in advance if you have had a gastric bypass: because the duodenum is bypassed, standard ERCP to retrieve a stone from the bile duct is difficult or impossible. Surgeons operating on bypass anatomy are advised to image the biliary tree during the operation for exactly this reason. It does not change what you do, but it explains why your team may approach a bile duct stone differently than they would in someone with normal anatomy. UrsodiolUrsodeoxycholic acid, sold as ursodiol, reduces cholesterol saturation in bile. It is commonly prescribed for about six months after surgery, and NIDDK notes that providers sometimes prescribe preventive medication for roughly that period. Typical dosing described in the clinical literature is 300 mg twice daily after gastric bypass or duodenal switch, and 500 mg daily after sleeve gastrectomy. Now the evidence, which is more interesting than the usual summary suggests. At preventing stones from forming, ursodiol clearly works. One randomized trial found gallstones in 43 percent of the placebo group versus 8 percent of the group taking 300 mg twice daily at six months after surgery. A 2023 meta-analysis of 12 randomized controlled trials conducted between 1993 and 2022, covering 2,767 patients, found a substantially lower overall incidence of gallstones with ursodiol, with a risk ratio of 0.13, and significant reductions at three months, six months and one year. At preventing symptomatic gallstone disease, the picture is less clean. The UPGRADE trial, a multicenter double-blind randomized placebo-controlled trial of 967 patients, gave 900 mg of ursodeoxycholic acid daily for six months after primary gastric bypass or sleeve gastrectomy. It did not significantly reduce symptomatic gallstone disease over two years in the population as a whole. A subgroup of bypass patients who had no gallstones before surgery did show a reduced risk, with an odds ratio of 0.37, and the authors suggested prophylaxis may be considered for that group specifically. The reasonable reading: ursodiol reduces the number of stones that form, and it probably reduces symptomatic disease in bypass patients who started with a clean gallbladder, but the effect on the outcome patients actually care about is smaller and less certain than the stone-formation numbers suggest. It is also a twice-daily pill for six months at a time when you are already swallowing a great deal, and adherence in the real world is imperfect. Whether you take it is your surgeon's call, and practices differ legitimately between programs. If you were prescribed it, take it for the full course. If you were not, that is a defensible position and not an oversight. Why routine gallbladder removal is no longer standardFor a period, some surgeons removed the gallbladder during the bariatric operation regardless of whether it contained stones, on the reasoning that they were already in there and it would save a second operation later. That practice has been abandoned, and the reasoning is straightforward arithmetic. Most patients never develop symptomatic gallstones, so most prophylactic cholecystectomies remove a healthy organ that would never have caused trouble. Adding the cholecystectomy lengthens the operation and adds its own complication risk, including bile duct injury. And the rate of biliary complications after bariatric surgery, at roughly 5.54 cases per 1,000 patient-years, is not high enough to justify operating on everyone. A systematic review and meta-analysis of cholecystectomy in bariatric patients concluded that prophylactic cholecystectomy may be avoided in favor of a selective approach: remove the gallbladder when it is clinically indicated, and monitor everyone else for symptoms. Current surgical society guidance addresses how to manage cholecystectomy in patients who already have bypass anatomy rather than recommending routine removal at the index operation. The one nuance is that if you already have known symptomatic gallstones going into your bariatric operation, doing both at once is often reasonable, and the same meta-analysis found lower complication and reoperation risk when cholecystectomy was done concomitantly rather than as a separate later procedure. That is a different situation from removing a healthy gallbladder. If you need your gallbladder out laterIt is a common outcome and not a sign that anything went wrong. Laparoscopic cholecystectomy after bariatric surgery is a routine operation, generally done as an outpatient or with a single overnight stay. You do not need a gallbladder. Some people have looser stools for a few weeks or months afterward, which usually settles. What matters is not sitting on the symptoms. Biliary colic that has become frequent, or any episode with fever or jaundice, is worth a call rather than a wait.

Deciding to pay for this yourself is a serious financial decision, and the industry that has grown up around it is not always on your side. Some of what follows is about how to pay. Most of it is about how not to get hurt while paying. Cash-pay package pricing Most bariatric programs offer a discounted bundled price to people paying cash. North Mississippi Health Services, for example, lists a $12,650 cash price for a vertical sleeve gastrectomy. UNC Rex states that self-pay options start at $8,999 depending on the operation. The discount is real, because the hospital avoids the administrative cost of a payer and gets paid up front. What varies wildly is what the bundle contains. North Mississippi's package includes the operating room, surgeon and anesthesia fees, up to two nights of hospitalization with nursing, labs, imaging, medications and a dietary consult, follow-up exams at two weeks, six weeks and three months, dietitian visits at two and six weeks, and eight weeks of wellness center membership. WakeMed describes its package as covering the day of surgery, facility fees, surgeon fee, anesthesia, an overnight stay, and five years of follow-up care. Get the inclusion list in writing and check it against this list of things that are often outside the bundle: Pre-operative labs, endoscopy or upper GI study, cardiac and pulmonary clearance, sleep study The psychological evaluation Pre-operative nutrition visits and the pre-op liquid diet products Follow-up beyond the stated window Complication care, readmission and reoperation The single biggest risk: a package that excludes complications This deserves its own section because it is the failure mode that turns a $13,000 decision into a $60,000 one. Most bariatric surgery goes fine. But in a Medicare study of 64,537 bariatric patients operated on between 2011 and 2016, 12.5 percent were readmitted within 90 days and 22.1 percent had an emergency department visit. If you are paying cash and you are readmitted for a leak, a bleed, an obstruction or a severe dehydration episode, the cash package almost certainly does not cover it, and you are now a self-pay inpatient with no negotiated rate. Before you sign anything, ask these questions and get the answers in writing: If I have a complication within 30 days, 90 days, or a year, what is covered and what is not? Does the package cover a reoperation for a complication of this surgery? Does it cover readmission to this hospital? What about a different hospital, if I am traveling? Is there a complication insurance product offered, what does it cost, what does it cover, and what does it exclude? If a program will not answer this clearly, that is your answer about the program. Your right to a written estimate, and to a discount you may already qualify for If you are uninsured or choosing not to use insurance, federal law entitles you to a good faith estimate of the cost before you receive care. If the final bill lands at least $400 above the estimate, you can use the patient-provider dispute resolution process. Separately, if the hospital is a nonprofit that is tax-exempt under section 501(c)(3), it operates under section 501(r) of the tax code. That requires it to have a written financial assistance policy, to limit what it charges patients eligible for that assistance to no more than amounts generally billed to insured patients, and to follow reasonable billing and collection practices. Ask for the financial assistance policy by name and ask whether you qualify. People routinely take out loans without ever asking this question. Medical credit cards and the deferred interest trap You will be offered one of these in the office. Understand exactly what you are being offered. A deferred interest promotion says something like no interest for 24 months. What it means is that interest is accruing the entire time at the card's regular rate, and it is being held back. If you pay the full balance off within the promotional window, the accrued interest is waived. If you are even slightly short on the final day, the entire accrued interest for the whole period is added to your balance at once. The Consumer Financial Protection Bureau reported interest rates well above traditional consumer credit cards, 26.99 percent for medical credit cards and 16 percent for medical installment loans, and that between 2018 and 2020 consumers paid roughly $1 billion in deferred interest charges on about $23 billion of medical financing across more than 17 million transactions. The CFPB also found that finance companies train providers and supply promotional materials to encourage enrollment, that providers often cannot explain deferred interest terms, and that patients frequently do not learn about hospital financial assistance or zero-interest options first. If you use one anyway, do three things. Divide the total by the number of promotional months and pay that amount every month, not the minimum, because the minimum payment is often deliberately too small to clear the balance in time. Set a calendar reminder two months before the promotion ends. Confirm the payoff amount by phone, not from the statement. Personal loans A fixed-rate personal loan from a bank or credit union is usually the less dangerous option, because the rate does not change and there is no cliff at the end. Compare on the annual percentage rate and the total amount repaid, not the monthly payment. Check for prepayment penalties. Get a quote from your own bank or credit union as well as from the financing partner the surgical office recommends, and remember that the office has a relationship with that partner. HSA and FSA Both let you pay with pre-tax dollars, which is effectively a discount equal to your marginal tax rate. A health savings account requires you to be enrolled in a qualifying high deductible health plan. For 2026, the contribution limits are $4,400 for self-only coverage and $8,750 for family coverage. The qualifying plan must have a minimum annual deductible of $1,700 self-only or $3,400 family, with maximum out-of-pocket amounts of $8,500 and $17,000. HSA funds roll over indefinitely and the account is yours if you change jobs, which is why it is worth understanding well before surgery rather than after. A health flexible spending arrangement is available with most employer plans and has no high deductible requirement. For 2026 the salary reduction limit is $3,400, with a maximum carryover of $680 if your plan permits carryover. The whole annual election is available to you on day one of the plan year, which is genuinely useful if your surgery is in January. The catch is the use-it-or-lose-it structure beyond the carryover. On what qualifies: IRS Publication 502 states you can include amounts paid to lose weight if it is treatment for a specific disease diagnosed by a physician, such as obesity. It also states you cannot include the cost of diet food or beverages, because they substitute for what you would normally eat. Nutritional supplements and vitamins are excluded unless recommended by a medical practitioner as treatment for a specific diagnosed condition, and health club dues are not deductible. Confirm the specifics with a tax professional, because your situation is yours. Employer programs and centers of excellence networks Two things are worth asking about even if you have concluded you are paying cash. First, some employers offer bariatric surgery through a designated network arrangement rather than as a standard medical benefit, often paired with travel support. North Mississippi Health Services, for example, notes that its bariatric center is a Cigna Center of Excellence and is recognized in the Optum bariatric centers of excellence network, which extends coverage through certain employer and government employee plans. If your employer uses one of those networks, the operation may be covered at a designated center even when it looks excluded at your local hospital. Ask HR specifically about centers of excellence. Second, if your employer self-funds its plan, the exclusion is your employer's decision and your employer can change it. That is a slower path than cash, but it is worth starting in parallel rather than instead. Shopping the price without shopping away the quality Comparing quotes is worth doing, and hospitals have to publish standard charges including discounted cash prices, so the numbers are more findable than they used to be. Ask every center for the same three things in writing: the total price, the itemized inclusion list, and the complication policy. Then compare those, not the headline number. Do not choose on price alone. A cheap package with a three-month follow-up window and no complication coverage is not cheaper than an expensive one with five years of follow-up and a defined readmission policy. It is a different product. What should actually disqualify a program is not its price. It is an unwillingness to put its inclusions, its exclusions and its complication policy on paper before you pay. Take the time to do this properly. You are about to spend a large amount of money on something that will change how you live, and an afternoon spent getting written answers is the cheapest insurance available to you.

If you have been quietly taking antacids for years and have never mentioned it to your surgeon, this article is for you. Reflux is the single most under discussed factor in choosing between a sleeve and a bypass, and it is now the leading reason sleeve patients end up having a second operation. It is worth ten minutes of your attention before you sign anything. What GERD is Gastroesophageal reflux happens when stomach contents come back up into your esophagus. Everyone has it occasionally. Gastroesophageal reflux disease, GERD, is the more severe and long lasting version where reflux causes repeated bothersome symptoms or leads to complications. NIDDK estimates that about 20 percent of people in the United States have GERD. The typical symptoms are heartburn and regurgitation, but not everyone gets those. Other presentations include chest pain, nausea, pain or difficulty swallowing, chronic cough and hoarseness. Untreated over time, GERD can cause esophagitis, which is inflammation that can ulcerate and bleed, esophageal stricture, which is narrowing that makes swallowing difficult, and Barrett's esophagus, in which the lining of the esophagus is replaced by tissue resembling intestinal lining. A small number of people with Barrett's develop esophageal adenocarcinoma. Complications outside the esophagus include asthma, chronic cough, laryngitis and erosion of tooth enamel. Two of the risk factors NIDDK lists are directly relevant here: having obesity, and having a hiatal hernia, which is when the opening in your diaphragm allows the top of the stomach to slide up into the chest. How reflux gets assessed before surgery Outside of surgery, GERD is usually diagnosed from symptoms and history alone, with testing reserved for people whose symptoms suggest a complication or who do not improve on treatment. Before bariatric surgery the threshold is much lower, because what is found changes which operation you should have. The IFSO position statement on upper gastrointestinal endoscopy before and after metabolic bariatric surgery says endoscopy should be strongly considered before surgery, while stopping short of calling it mandatory. The reasoning is that symptoms predict pathology poorly. In the pooled data, 61 percent of patients had some abnormal finding on preoperative endoscopy. The common findings were gastropathy in 33 percent, hiatal hernia in 22 percent and esophagitis in 16 percent. Serious findings such as cancer or varices occurred in under 1 percent, and findings that entirely contraindicate surgery were similarly rare. The number that matters most to you is this one: roughly 23 percent of patients had findings that led to a change in the type of procedure planned, and about 35 percent needed treatment for something that was found. Nearly a quarter of people went in expecting one operation and had the plan revised. That is the whole argument for getting scoped. Other tests your team may use include esophageal pH monitoring, which NIDDK describes as the most accurate way to detect stomach acid in the esophagus, and manometry to assess how well the esophagus moves. Whether you need these is a clinical decision for your surgeon and gastroenterologist. Why the sleeve can cause or worsen reflux The sleeve removes the fundus, narrows the stomach into a high pressure tube, and can disturb the angle where the esophagus meets the stomach. If a hiatal hernia is present and not addressed, the anatomy that normally resists reflux is further compromised. The result is that a meaningful proportion of sleeve patients develop new reflux or find existing reflux gets worse. Here the evidence is genuinely contested, and you should be given a range rather than a number. A meta-analysis of nine studies found the odds of GERD were 3.61 times higher after sleeve gastrectomy, and pooled new onset GERD at 50.8 percent. Pooled erosive esophagitis by Los Angeles grade was 23.1 percent class A, 14.6 percent class B, 4.3 percent class C and 3.3 percent class D. Pooled Barrett's esophagus was 7.3 percent. The authors concluded that endoscopic surveillance is warranted after sleeve even in patients with no reflux symptoms. A review of studies with 10 years or more of follow up, covering 1,020 patients, put new onset GERD at 32.3 percent with a range of 21.4 to 58.4 percent, and found Barrett's in 0.5 percent. The IFSO endoscopy statement cites de novo Barrett's esophagus at approximately 3.53 percent after sleeve. In the SLEEVEPASS randomized trial at 10 years, esophagitis was found in 31 percent of sleeve patients against 7 percent of bypass patients, and 64 percent of sleeve patients were taking proton pump inhibitors against 36 percent after bypass. Barrett's esophagus was found in 4 percent of each group, with no statistically significant difference between them. Why the enormous spread? Because studies measure different things. Symptom questionnaires and endoscopic findings disagree with each other in both directions, some people have esophagitis without symptoms and some have symptoms without visible damage. Follow up lengths differ. Whether hiatal hernias were sought and repaired differs. And Barrett's estimates in particular swing from under 1 percent to over 7 percent depending on who was scoped and when. What is consistent across every one of these sources is the direction. Reflux is more common after sleeve than after bypass, and it does not reliably settle down with time. The other side is real too. Obesity itself causes reflux, and losing a large amount of weight relieves it for some people. Some sleeve patients see their pre-existing reflux improve. You should not assume you will be in that group, and you should not assume you will not be. Why bypass generally improves reflux After a Roux-en-Y gastric bypass, acid is produced in the remnant stomach, which is no longer connected to your esophagus. The small pouch holds very little and has no significant acid production of its own. Anatomically, the path for acid to reach the esophagus is largely gone. The behavioral changes help as well. You eat smaller meals, you eat more slowly, and the post operative diet limits fatty foods, alcohol and caffeine, all of which aggravate reflux. This is why gastric bypass is often recommended outright when a patient has significant GERD going in, and it is why the SLEEVEPASS esophagitis and PPI figures separate so sharply. Hiatal hernia repair at the time of surgery If you have a hiatal hernia, your surgeon should identify it and repair it during your bariatric operation, usually by approximating the crura of the diaphragm behind the esophagus. This is standard practice and it is worth confirming it is in your plan. Be clear eyed about what it buys you. A meta-analysis of sleeve gastrectomy with concurrent hiatal hernia repair found significant reduction in GERD symptoms with an odds ratio of 0.20 and improvement in esophagitis with an odds ratio of 0.12. GERD remission occurred in 68 percent. Compared with sleeve alone, the combined procedure was clearly better for resolving existing GERD, with an odds ratio of 2.97. However, de novo GERD still occurred in about 12 percent, and there was no significant difference in de novo GERD between sleeve with hernia repair and sleeve alone. Hiatal hernia recurrence was 11 percent. So repairing the hernia helps existing reflux considerably. It does not appear to prevent new reflux from developing. That distinction is often blurred in consultations and it should not be. Barrett's esophagus Barrett's is a change in the esophageal lining caused by chronic acid exposure, and it is the main reason reflux is treated as more than a comfort issue. If you already have Barrett's, the IFSO position is that bypass procedures may be preferred over reflux promoting procedures like sleeve gastrectomy, arrived at through shared decision making, and that you should continue standard gastroenterology surveillance rather than a bariatric specific schedule. Post sleeve surveillance guidance has actually loosened. Rather than routine endoscopy every two to three years for everyone, the current suggestion is endoscopy for patients with alarm symptoms such as difficulty swallowing, unexplained weight loss or bleeding, or for refractory reflux. Your gastroenterologist decides what applies to you. Conversion from sleeve to bypass This is now one of the most common operations in bariatric surgery. In the MBSAQIP database for 2020 and 2021, 13,432 patients underwent conversion from sleeve to bypass compared with 84,543 primary bypasses. GERD was the indication in 55.3 percent of those conversions, ahead of weight regain at 24.4 percent and inadequate weight loss at 12.7 percent. A separate MBSAQIP analysis of 2020 data found sleeve to bypass was the single most common conversion performed, at 40.3 percent of all conversions, with GERD driving 54.2 percent of them. Conversion is safe but not free. Compared with primary bypass, conversion had longer operative times, 145 minutes against 125, and a higher rate of serious complications, 7.2 percent against 5.0 percent. Anastomotic leak was 0.5 percent against 0.4 percent, bleeding 2.0 percent against 1.6 percent, and reoperation 3.0 percent against 1.9 percent. Mortality was 0.1 percent in both groups and was not different. Conversion was an independent predictor of serious complications but not of death. For most people with intractable reflux after a sleeve, those odds are acceptable. It is still a second operation, and knowing that going in is better than discovering it in year four. What to do with all of this Tell your surgeon about every antacid, every episode of night time coughing, every time food has come back up. Underreporting reflux to get the operation you already picked is a bad trade. Ask whether you are getting a preoperative endoscopy and what it showed. Ask specifically whether you have a hiatal hernia and whether it will be repaired. If you have esophagitis or Barrett's, expect a serious conversation about bypass rather than sleeve. After surgery, do not treat persistent heartburn as normal. Reflux that needs daily medication long term deserves investigation. None of this is a reason to avoid surgery. It is a reason to have the right one.

Your surgeon told you no ibuprofen, probably more than once, possibly with unusual firmness. This is why. It is also the part of post-operative instructions that gets quietly abandoned first, usually around the time a knee starts hurting or a dentist hands over a prescription without asking what operation you had. What a marginal ulcer isAfter a Roux-en-Y gastric bypass, the small gastric pouch is connected directly to the jejunum. That connection is called the gastrojejunal anastomosis, and the ulcer that forms just past it, on the jejunal side, is called a marginal ulcer. The jejunum is not built for acid. The stomach lining has a thick mucus layer, bicarbonate secretion, and a blood supply designed for the job. Jejunal mucosa has none of that. It normally sits downstream of the duodenum, where pancreatic bicarbonate has already neutralized whatever came out of the stomach. After a bypass, acid from the pouch hits it directly, and pepsin gets activated locally by that acidity. Add anything that impairs mucosal defense or blood supply, and you get an ulcer. Sleeve gastrectomy does not create this anatomy, so marginal ulcers are a bypass problem. Sleeve patients can still get ulcers, but the mechanism and location differ. How commonReported incidence after gastric bypass has a mean of about 4.6 percent, with individual studies ranging from 2.3 percent to 18.6 percent depending on whether they included asymptomatic patients and how long they followed people. An ASMBS literature review published in 2024 collects rates running from 0.9 percent at one year of follow-up to 11.4 percent at eight years. Most ulcers develop 6 to 12 months after surgery, but the reported range runs from 14 days to 20 years. There is no point past which you are safe, which is why the NSAID rule is permanent rather than temporary. The risk factors, ranked by how much control you haveNSAIDs. Associated with roughly a 3.1-fold increase in risk. Higher doses and chronic use matter more than an occasional low dose, but the safest position after a bypass is none. This includes ibuprofen, naproxen, diclofenac, ketorolac, meloxicam, indomethacin, aspirin above a cardiac-protective dose, and the many combination cold and headache products that contain one of them without saying so on the front of the box.Smoking. Smokers have a 56 percent higher hazard of developing a marginal ulcer, and 17.8 percent of smokers develop one within eight years. One review puts the risk increase as high as 4.6-fold. Even light smoking, under 10 cigarettes a day, raises risk. This includes nicotine in other forms; ask your surgeon specifically about vaping and nicotine pouches, because programs differ.Immunosuppression, including chronic steroids, associated with about a 4.6-fold increase.Poorly controlled diabetes. Each unit of HbA1c above 6.0 percent has been associated with a 23 percent increase in risk.Helicobacter pylori. The evidence is genuinely conflicting. Meta-analyses have found up to a tenfold increase in risk with H. pylori infection, while smaller controlled studies found no association and some found the opposite. The 2024 ASMBS review concluded that no strong recommendation can be made about testing for H. pylori specifically to prevent marginal ulcer. Many programs test and treat before surgery anyway, for other good reasons.A larger gastric pouch, because more parietal cell mass means more acid. In one case-control study, each 5 cubic centimeter increase in pouch volume carried about 2.4 times the odds of an ulcer. This is a surgical variable, not a patient one.How it feelsThe typical presentation is burning or gnawing pain high in the abdomen or behind the breastbone, often worse when the pouch is empty, sometimes relieved briefly by eating and then worse afterward. Nausea and a new intolerance of foods you were previously handling are common. Some people describe it as their restriction suddenly getting much tighter. Some marginal ulcers are silent until they bleed or perforate. Signs that an ulcer has bled include black tarry stools, vomiting material that looks like coffee grounds, lightheadedness, or a new anemia found on routine labs. Perforation causes sudden severe pain and a rigid abdomen. Both are emergencies. Diagnosis and treatmentUpper endoscopy is the gold standard, and it is the only reliable way to make the diagnosis. Routine endoscopy in patients without symptoms is not recommended, because asymptomatic ulcers are uncommon enough that screening does not pay off. Endoscopy is for people with symptoms. Treatment is acid suppression with a proton pump inhibitor, often combined with sucralfate, which coats the ulcer bed. Open-capsule PPI dosing, where the capsule is opened and the granules taken directly, is used because the small pouch and fast transit may not give an intact capsule time to dissolve where it should. In one series, patients treated with open-capsule PPIs had a median healing time of about three months. Smoking cessation and stopping the offending drug are part of the treatment, not optional additions to it. Most marginal ulcers heal medically. Surgery, in the form of revision of the anastomosis, is reported in 3.9 percent to 33 percent of cases across series, reserved for ulcers that will not heal, that keep coming back, that bleed uncontrollably, or that perforate. ProphylaxisProton pump inhibitors given routinely after bypass reduce the odds of marginal ulcer by 50 to 70 percent, and in one comparison dropped incidence from 7.3 percent to 1.2 percent. The 2024 ASMBS review recommends at least three months of PPI prophylaxis after gastric bypass. Longer courses are recommended for patients who smoke, who must take NSAIDs, who are on immunosuppression, or who have had an ulcer before. If you were sent home on a PPI, take it for the full course. Stopping it at week six because you feel fine is a common and avoidable mistake. The medication rules you were given, and the reasons behind themNothing else on this site covers post-operative medication management, so here it is in one place. These are general principles. Every specific decision about your own prescriptions belongs to your surgeon and your pharmacist together. FormulationBariatric anatomy changes drug absorption in several ways at once: a much smaller stomach means less room and less time for a tablet to disintegrate, gastric pH rises so acid-soluble drugs dissolve poorly, the available intestinal surface area is reduced after a bypass, and everything moves through faster. Extended-release, modified-release, enteric-coated and film-coated formulations should be avoided where possible. They are engineered to release drug slowly over a defined transit time. When transit is faster and the absorptive surface is shorter, a slow-release tablet can pass through without delivering its full dose. Immediate-release formulations are preferred.Liquid, dispersible or crushed forms are typically used for the first several weeks. Guidance from NHS Specialist Pharmacy Service suggests patients can usually return to solid dosage forms after roughly 6 to 8 weeks on a normal diet. Note that cutting or crushing a tablet may make its use off-label, so this is a question for your pharmacist rather than a decision to make at the kitchen counter.Choose low-sugar liquid preparations, since sugary syrups can provoke dumping.Avoid effervescent formulations, because the carbonation is poorly tolerated after surgery.MonitoringDo not assume a change is needed based on any one of these effects in isolation. What is called for is frequent monitoring for reduced effect or new side effects, particularly for drugs with a narrow therapeutic index. That means antiepileptics, thyroid hormone, lithium, warfarin, immunosuppressants, and psychiatric medications where a small change in level matters. Weight-based doses, levothyroxine being the standard example, need adjusting as your weight falls. Interactions with your supplementsCalcium impairs iron absorption, so iron and calcium supplements should be taken at separate times of day. Taking iron with 500 to 1000 mg of vitamin C, or with meat, improves absorption. If oral iron cannot keep up, intravenous iron is an option. Pain control without NSAIDsThis is the question everyone actually has. Acetaminophen is the usual first line. Topical agents, physical therapy, and non-drug approaches carry more weight than they did before your operation because the easy option is off the table. If you need something stronger, that is a conversation with your prescriber, who should know you have had a bypass. Tell every new clinician, every dentist, and every urgent care doctor. They will not think to ask.

Medicare and Medicaid get lumped together in conversation, and for bariatric surgery they could hardly be more different. Medicare has one national rule that applies in every state. Medicaid has fifty-some separate answers. If you are covered by either, the first thing to know is which of those two worlds you are in. What Medicare covers Medicare's coverage comes from National Coverage Determination 100.1, Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity. It has been in force since February 2006 and it names specific procedures. Nationally covered: Roux-en-Y gastric bypass, open and laparoscopic Biliopancreatic diversion with duodenal switch, also called gastric reduction duodenal switch, open and laparoscopic Laparoscopic adjustable gastric banding Sleeve gastrectomy sits in a different category. Since June 27, 2012, Medicare Administrative Contractors have had the authority to decide coverage of stand-alone laparoscopic sleeve gastrectomy within their own jurisdictions. In practice they generally do cover it. The local coverage determination for bariatric surgical management of morbid obesity covers laparoscopic sleeve gastrectomy as a stand-alone procedure. The practical consequence is that sleeve coverage is a regional decision, so confirm it with your own contractor rather than assuming. Nationally non-covered, meaning Medicare will not pay for them anywhere: Open adjustable gastric banding Open and laparoscopic vertical banded gastroplasty Open sleeve gastrectomy Intestinal bypass surgery Gastric balloon procedures The Medicare eligibility criteria You must meet all three: A body mass index of 35 or higher At least one comorbidity related to obesity. Type 2 diabetes has counted since February 2009. Previous unsuccessful medical treatment for obesity Note that Medicare's threshold is a BMI of 35 with a comorbidity, not 40. Note also that the third criterion is real and is where documentation problems arise. The local coverage determination expects failed medical treatment to be documented through participation in structured dietary programs overseen by a physician, a registered dietitian or another qualifying nutrition professional. It also expects documentation of comorbid conditions through physiologic testing or imaging, evidence of preoperative and postoperative evaluations, and a psychological evaluation for patients with a psychiatric history. The facility requirement, which no longer exists If you read older material, you will find that Medicare once required surgery to be performed at a facility certified under a specific bariatric accreditation program. That requirement was removed. As of September 24, 2013, facility certification is no longer required for coverage of covered bariatric procedures. That said, choosing an accredited center is still worth doing on quality grounds. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program, run by the American College of Surgeons, accredits centers after independent peer evaluation, and nearly 1,000 sites participate. You can search accredited centers through the ACS hospital finder. What you actually pay under Medicare Medicare.gov states that bariatric procedures are covered under Part B when you meet the conditions, and that your cost depends on your Part A deductible if you are admitted as an inpatient, your Part B deductible for physician and outpatient services, copayments after those deductibles, whether the surgery is done as an inpatient stay or in a hospital outpatient department or ambulatory surgical center, and whether your doctor accepts assignment. Medicare does not cover your transportation to a bariatric center. For 2026, the Part A inpatient hospital deductible is $1,736 per benefit period. The Part B annual deductible is $283, and the standard Part B monthly premium is $202.90. Coinsurance for inpatient days 61 through 90 is $434 per day. Original Medicare has no annual out-of-pocket maximum. That is why most people carry either a Medigap policy or a Medicare Advantage plan, and it is worth confirming what yours does before surgery rather than after. Medicare Advantage is not the same thing A Medicare Advantage plan must cover everything Original Medicare covers, so the national coverage determination still sets the floor. What differs is everything around it: Prior authorization. Original Medicare does not require prior authorization for bariatric surgery. Advantage plans routinely do, and the plan applies its own utilization criteria on top of the Medicare rules. Networks. Your surgeon and hospital have to be in the plan's network, or you pay much more, or nothing is covered at all. Cost sharing. Copayments and coinsurance are set by the plan, not by Medicare. Advantage plans do have an annual out-of-pocket maximum, which Original Medicare does not. Appeals. You appeal to the plan, on the plan's timeline, before you get to independent review. If you are in an Advantage plan, get the plan's own bariatric coverage policy in writing. Do not rely on the national coverage determination alone, and do not rely on what a hospital told a patient in a different plan. Medicaid: the honest answer is that it depends on your state Medicaid is a joint federal and state program, and states run their own. Federal law defines a set of mandatory benefits every state must cover, including inpatient and outpatient hospital services and physician services, and a set of optional benefits states may choose. Beyond that, Medicaid.gov states plainly that states establish and administer their own programs and determine the type, amount, duration and scope of services within broad federal guidelines. Bariatric surgery is not named in the federal mandatory list. What that means in practice: Some state Medicaid programs cover bariatric surgery with criteria that look much like commercial policies. Some cover it with tighter criteria, longer supervised weight loss requirements, or a narrower list of approved procedures. Some do not cover it. Coverage changes. A state that did not cover it three years ago may cover it now, and the reverse happens too. Anyone who tells you confidently what Medicaid covers without asking which state you live in is guessing. So is any national list you find online, because those lists go stale fast and the underlying rules move. How to get the real answer for your state Do these in order. Call your state Medicaid agency directly and ask whether bariatric surgery is a covered service, and if so, what the medical necessity criteria are. Ask for the coverage policy or provider manual section in writing. Use the same phrasing that works with commercial plans: ask whether it is covered when it is medically necessary, not simply whether it is covered. If you are in a Medicaid managed care plan, and most enrollees are, call the managed care plan too. The plan administers the benefit and applies its own prior authorization criteria within what the state allows. Call a bariatric program in your state and ask their insurance coordinator whether they take Medicaid and how often those cases get approved. Coordinators at high-volume centers know the current state of play better than any published document. Ask about the specific procedure. A state may cover sleeve gastrectomy and not duodenal switch, or the reverse. Ask about revisions separately. Coverage of a first operation tells you nothing about coverage of a second. Find your own state, in one click The Obesity Action Coalition keeps a directory of state agencies, and for each state it lists the Medicaid agency, the Department of Insurance and the state health department, with phone numbers and addresses. The Department of Insurance entry matters as much as the Medicaid one, because that is the office you escalate to when a commercial plan denies you and the internal appeal goes nowhere. One caveat before you use it. Some of these pages are old enough that the agency names have changed since they were written, and a few of the outbound links point at web addresses the states have since retired. Treat the phone numbers and the agency identity as the useful part, and search for the current website yourself if a link does not resolve. AlabamaAlaskaArizonaArkansasCaliforniaColoradoConnecticutDelawareFloridaGeorgiaHawaiiIdahoIllinoisIndianaIowaKansasKentuckyLouisianaMaineMarylandMassachusettsMichiganMinnesotaMississippiMissouriMontanaNebraskaNevadaNew HampshireNew JerseyNew MexicoNew YorkNorth CarolinaNorth DakotaOhioOklahomaOregonPennsylvaniaRhode IslandSouth CarolinaSouth DakotaTennesseeTexasUtahVermontVirginiaWashingtonWashington DCWest VirginiaWisconsinWyoming A fair number of states do not call their program Medicaid at all, which is a common source of confusion when you are searching. California runs Medi-Cal, Tennessee runs TennCare, Kansas runs KanCare, Maine runs MaineCare, Connecticut runs HUSKY, Arizona runs AHCCCS, Hawaii runs Med-QUEST, Oregon runs the Oregon Health Plan and Vermont runs Green Mountain Care. If a search for your state plus the word Medicaid returns nothing useful, search the program name instead. For the program itself rather than the contact details, the federal Medicaid site publishes a profile for every state and territory covering eligibility and enrollment. It will not tell you whether bariatric surgery is covered, because that sits in state policy manuals rather than in the federal profile, but it is the right place to confirm what your state actually runs and who runs it. If you are covered by both If you are dually eligible for Medicare and Medicaid, Medicare pays first and Medicaid may cover some of what Medicare leaves. That combination can be favorable, but it also means two sets of rules and two sets of prior authorization. Ask the bariatric program's coordinator to walk you through the order of operations before you start, because getting the sequence wrong creates denials that are tedious to unwind. The part worth being blunt about Public coverage for bariatric surgery is real and it works, and it is also the slowest lane in this system. Documentation requirements tend to be stricter, approval timelines longer, and the list of participating centers shorter. None of that means you will not get there. It means you should start earlier than a commercially insured person would, keep every piece of paper, and be prepared to ask the same question three times before you get a consistent answer.

This site started as a lap band support forum. A lot of us, including me, had a band placed when it was the operation everyone was talking about. It is now one of the least performed procedures in the country. Both of those things are true at once, and neither one makes anybody who chose a band foolish. You made a reasonable decision with the information that existed. The information changed. What the band was and why it made sense The adjustable gastric band is an inflatable silicone ring placed around the top of the stomach, creating a small pouch above it while leaving the rest of the stomach intact below. A port sits under the skin, and saline can be added or removed to tighten or loosen the opening between pouch and stomach. NIDDK describes it as making you feel full after a small amount of food, with follow up visits to adjust the opening. The FDA approved laparoscopic gastric banding in 2001, and within the decade it became the most popular weight loss operation in the United States. The reasons were not marketing. Nothing was cut out, nothing was rerouted, your anatomy stayed intact, the band could be adjusted to your needs and removed entirely if you wanted, the operation was fast, the hospital stay was short, and the early complication rate was the lowest of any bariatric procedure. One meta-analysis put complication rates at 13 percent for banding against 21 percent for gastric bypass. A 10 year randomized trial found early complications of 8.3 percent after bypass against zero after banding. If you were making a decision in 2005, all of that was real and all of it was in the band's favor. What the long term data showed The problem was that the early numbers did not predict the late ones. As the follow up got longer, a different picture emerged. A 12 year follow up series reported minor complications in 22 percent of band patients and major complications in 39 percent, including band erosion in 28 percent. Broader reviews describe long term complication rates as high as 40 to 50 percent, with reoperation rates as high as 30 percent, and other reports put the reoperation range at 16 to 60 percent, rising steadily with time. A single center review of 305 band patients found 13.8 percent needed reoperation at three years. Gastric prolapse was the most common reason for band removal at 4.6 percent, and port problems were the most common reason for revision. Early reoperations, under two years, were mostly port revisions. Later ones were mostly removals. UCLA states that more than half of gastric bands are removed for inadequate weight loss or complications within 7 to 10 years. The recognized band problems are slippage or prolapse, erosion of the band into the stomach, port and tubing malfunction and infection, esophageal dilation and dysmotility from chronic obstruction, esophagitis and reflux, food intolerance with vomiting and difficulty swallowing, and inadequate weight loss or regain. The evidence is not entirely one sided and it would be dishonest to pretend otherwise. A large systematic review by O'Brien published in 2019 reported 45.9 percent excess weight loss at 10 years or more after banding, compared with 56.7 percent for gastric bypass, 58.3 percent for sleeve and 74.1 percent for biliopancreatic diversion, which is a respectable durable result. That group also reported that revision need exceeded 50 percent in the era of the original 10 cm band but fell sharply below 10 percent with newer band designs, better technique and better patient education. A 20 year series of 3,566 patients reported excess weight loss of 49 percent, 52.6 percent and 59.2 percent at 10, 15 and 20 years with pouch dilatation in 5.8 percent and erosion in 2.5 percent. So the range is genuinely wide, and outcomes depended heavily on band generation, surgical technique and how closely patients were followed. What is not in dispute is the direction of travel across the field as a whole. The collapse in volume Bands made up 35.4 percent of all United States bariatric procedures in 2011. That fell to 20.2 percent in 2012, 14 percent in 2013, 9.5 percent in 2014 and 5.7 percent in 2015. By 2023, ASMBS estimated 773 band procedures out of 270,089 total, which is 0.3 percent. The 2022 ASMBS and IFSO guideline states simply that the popularity of the adjustable gastric band has diminished significantly over the past decade. Many large centers, including UCLA, no longer place bands at all and no longer perform band adjustments, though they will evaluate you for removal or conversion. That is the practical reality you are working within if you still have one. If you still have a band and it is working A working band is a working band. Nobody should talk you out of a good result. What you need is proper surveillance, because the problems that develop are slow and often quiet. Find a program that will follow you. If your original surgeon has stopped doing band care, ask a comprehensive bariatric center whether they manage existing bands. Do not simply stop being followed. That is how esophageal dilation goes unnoticed for years. Do not chase restriction with more fill. An over tightened band is the mechanism behind most of the esophageal problems. If you need frequent tightening to feel restriction, that is information, not a target. Report new symptoms rather than adapting to them. New or worsening heartburn, food getting stuck, regurgitating undigested food, night time coughing or choking, vomiting more than occasionally, or a sudden inability to tolerate what you used to eat are all reasons to be seen. Sudden severe pain and vomiting can mean a slip and needs urgent attention. Watch the port site. Redness, pain, swelling or drainage over the port can indicate infection, and port infection often means the band has eroded into the stomach. Expect imaging or endoscopy when symptoms warrant it. Your team decides what and when. Reflux that does not respond to acid suppression should be investigated rather than medicated indefinitely, because chronic untreated reflux can lead to stricture and Barrett's esophagus. Keep taking your vitamins and getting labs. Bands do not cause malabsorption, but restricted eating still produces deficiencies. If your band is not working The common reasons bands come out are inadequate weight loss or regain, band intolerance with persistent nausea, vomiting or difficulty swallowing, band or port infection, slippage, severe heartburn that does not respond to medication, and esophageal dilation, dysmotility or esophagitis. Some of these can be managed first by removing fluid from the band or repositioning it. Others need the band out. Removal itself is usually straightforward and done laparoscopically, often through the old incisions. One technical point worth raising with your surgeon: at the original operation, the top of the stomach was usually sutured over the band to hold it in place. Those sutures and the surrounding adhesions should be taken down at removal to restore normal anatomy, which matters if you are converting to another procedure now or later. What conversion involves Band conversions are a large part of modern bariatric practice. In the MBSAQIP database for 2020, conversions accounted for 73.7 percent of all revisional procedures, and adjustable band was the index operation in 45.9 percent of those conversions, second to sleeve gastrectomy at 49.3 percent. Band to sleeve made up 27 percent of all conversions and band to bypass 16.2 percent. Weight loss failure was the indication in 67 percent of band to sleeve cases and 61.3 percent of band to bypass cases. Across all conversion types in that analysis, overall morbidity ranged from 5.3 to 20.8 percent, serious morbidity from 2.3 to 19.2 percent, reoperation from 1.5 to 10 percent, and mortality from zero to 0.8 percent. Revisional surgery carries higher complication rates than primary surgery. That is consistent across the literature and you should hear it stated clearly before you consent. Whether you convert in one operation or two, and whether you convert to a sleeve or a bypass, are decisions for you and your surgeon. Both destinations have produced good weight loss results after band removal. Reflux history, esophageal function, scarring at the band site and your own priorities all feed into the choice. If your main problem with the band was reflux and esophageal irritation, that argues in one direction. If it was simply not enough weight loss, the conversation is different. One last thing There is a tone in some bariatric writing that treats band patients as though they picked wrong. Ignore it. You had an operation that the field endorsed, in a decade when it was the leading choice, and a great many people did well on it for years. Where the band ended up is a story about long term evidence, not about you. What matters now is that you are followed properly, that you get symptoms looked at instead of living around them, and that if the band has stopped working for you, you know a good next step exists.

A leak is the complication people fear most, and the fear is not irrational: it is the one that puts you back in the hospital and occasionally in the intensive care unit. What has changed is how often it happens. If you are reading older patient material, including older editions of books published under the BariatricPal name, you may see leak rates quoted in the double digits. Those numbers were wrong when they were printed and they are badly wrong now. Current national registry data puts the 30-day leak rate under 1 percent. What a leak isEvery bariatric operation creates at least one new join. A sleeve gastrectomy creates a long staple line down the length of the stomach. A gastric bypass creates a staple line on the pouch plus two anastomoses, one connecting the pouch to the jejunum and one connecting the two limbs of intestine. A leak is a failure at one of those points that lets gastric or intestinal contents escape into the abdominal cavity. That is why leaks make you sick systemically. The escaped contents cause peritonitis and set off a body-wide inflammatory response, which is why the earliest sign is usually a change in vital signs rather than a change in how your abdomen feels. The current rates, and why sources disagreeTwo large recent analyses of the MBSAQIP database, the American national accreditation registry, give the cleanest current picture: A six-year analysis of 692,554 primary sleeve gastrectomies performed between 2016 and 2021 found leaks within 30 days in 1,179 patients, a rate of 0.17 percent. Leak odds were higher in 2016 to 2019 than in 2020 to 2021, so the trend is downward.A 2025 analysis of 193,847 patients in the MBSAQIP 2022 dataset found leaks in 0.1 percent after sleeve gastrectomy and 0.2 percent after gastric bypass.Meanwhile, review articles and single-center series report higher numbers: 1.5 percent to 3 percent for sleeve gastrectomy and 0.3 percent to 2 percent for gastric bypass in one standard reference, and ranges as wide as 1 percent to 7 percent for sleeve and 0.6 percent to 4.4 percent for bypass in another. Do not average these. They are measuring different things. Follow-up window. Registry figures are 30-day. Some leaks present later, and series with longer follow-up capture them.Case mix. Revisional operations leak more than primary ones. A re-sleeve or a conversion carries more risk than a first-time sleeve, and registry analyses of primary cases exclude them.Center and surgeon volume. Higher-volume bariatric surgeons have lower leak rates. One MBSAQIP analysis found general surgeons performing robotic sleeves had higher leak rates than bariatric specialists, consistent with a learning curve.Definition. Some series count any radiographic contrast extravasation. Others count only clinically significant leaks requiring intervention.The number to hold in your head for a primary sleeve or bypass at an accredited center is well under 1 percent, with older literature running higher for the reasons above. When leaks show up and how they announce themselvesThe average time from operation to symptoms is about three days, which means many leaks declare themselves after you have gone home. Sleeve leaks are classified by timing as acute within 7 days, early at 1 to 6 weeks, late after 6 weeks, and chronic after 12 weeks. The signs, in rough order of usefulness: Sustained tachycardia, particularly a resting heart rate over 120 that will not settle. In one study of vital signs after bypass, 7 of 8 patients with a leak had sustained tachycardia above 120.Fever.Abdominal pain, which may be severe or may be surprisingly mild.Shortness of breath or rapid breathing.Left shoulder pain, from irritation of the diaphragm.A general sense of being unwell that you cannot explain.Diagnosis is usually by CT scan with oral contrast, chosen for its sensitivity and because it also shows collections and abscesses. Blood work shows a rising white count. Some centers add a contrast swallow study. How leaks are treatedTreatment depends on how sick you are and how long the leak has been present. Almost all patients get antibiotics, bowel rest, and nutrition delivered some other way, either intravenously or through a feeding tube placed past the leak. Fluid collections are drained, usually by an interventional radiologist through the skin. Beyond that, endoscopic treatment has largely replaced reoperation as the first choice. A meta-analysis of 58 studies covering post-sleeve leaks reported an overall endoscopic success rate of 88 percent. Broken down by technique: Endoscopic suturing: 91 percent success.Stenting, the most commonly used approach at about 48 percent of cases: 90.6 percent success. A covered stent is placed across the leak so that food and secretions pass through the stent rather than out through the defect, letting the tissue heal.Endoscopic vacuum therapy: 85.1 percent success.Internal drainage, where pigtail drains are placed through the defect into the collection: 84.5 percent success.Over-the-scope clips: 77.1 percent success.Stents are not free of trouble. The most common problems are stent migration, reported in about 24.5 percent of cases, and stricture at about 5 percent. A migrated stent usually just needs repositioning or replacement. Surgery is still needed for patients who are unstable, for large defects, and for chronic leaks that will not close. Where surgery is required for chronic cases, reported closure rates run from about 75 percent to 100 percent depending on which operation is used. The important thing to know as a patient is that a leak is usually a long problem rather than a catastrophic one. It often means weeks of drains, antibiotics and repeat endoscopy. It is exhausting and demoralizing. It is usually survivable and fixable. StricturesA stricture is the opposite problem: instead of a connection that opens up, you get one that scars down and narrows. It is far more common than a leak and far less dangerous. After a gastric bypass, the gastrojejunal anastomosis is the usual site. Reported rates vary a good deal with technique, particularly the size of the circular stapler used: one series using a 21 mm circular stapler reported a 9.4 percent stricture rate, while a broad review cites 8 percent to 19 percent for stenosis after bypass. After sleeve gastrectomy, true stricture is uncommon at roughly 0.69 percent to 2 percent, though kinks and twists of the sleeve occur in up to 9 percent and cause similar symptoms. How a stricture feelsIt is a swallowing problem, not a pain problem. In one series, patients presented with vomiting, difficulty swallowing solids and then liquids, and little or no abdominal pain. The classic progression is that solid food starts sticking, then soft food, then eventually liquids and even saliva. People often describe feeling like food is hanging up in their chest, and many of them start eating less and quietly congratulate themselves on their restriction before realizing they are also not keeping fluids down. Timing is the giveaway. In one series, 73 percent of strictures presented more than 30 days after surgery, with a median of 42 days. If your ability to swallow was fine at three weeks and is worse at seven, that is a stricture until proven otherwise, and it is a call to the office. How strictures are treatedEndoscopic balloon dilation, and it works well. In one series, 14 of 15 patients were resolved endoscopically, a 93 percent success rate, with just over half needing only a single session and 15 mm the most common maximum balloon size. No complications occurred during any of the dilations in that series, and only one patient needed surgical revision after failed endoscopic treatment. You may need more than one dilation, spaced a few weeks apart. That is normal and is not a sign that anything has gone wrong. What you should take from thisLeaks are rare and getting rarer, and the tools for handling them have improved substantially. Strictures are more common, more annoying, and reliably fixable in an outpatient endoscopy suite. Both of them reward being reported early, and both of them get worse if you wait to see how it looks in a few days.

The letter arrives and your stomach drops. Before anything else, understand two things. First, a denial is a first answer, not a final one. In 2024, insurers on the ACA marketplace overturned 34 percent of the in-network denials that consumers appealed. Second, almost nobody appeals. Fewer than 1 percent of denied in-network claims were appealed at all. The people who fight are a tiny minority, and a third of them win. Read your letter and find the stated reason. Everything below is organized by that reason, because the reason determines what evidence works. Before you write anything: get the file You have the right to a free copy of every document relevant to your claim, including the specific internal rule, guideline or clinical criteria the plan relied on to deny you. Request it in writing, by name. You cannot rebut criteria you have not read, and plans deny using criteria that are sometimes years out of date. Also ask what codes were submitted. A meaningful share of denials are coding problems wearing a medical costume. Denial reason: not medically necessary What it means. The reviewer decided your documentation does not establish that you meet the plan's clinical criteria. Usually one specific criterion is unmet, or the evidence for it was not in the packet. What rebuts it. Read the plan's own criteria list, item by item, and answer each one with a document. If the criterion is a BMI of 40 or a BMI of 35 with a comorbidity, supply dated weights and the comorbidity documentation. If the criterion is documented failure of conservative therapy, supply the record of it. Where your documentation is complete and the criteria themselves are outdated, argue that. The 2022 ASMBS and IFSO guidelines recommend surgery at a BMI of 35 or higher regardless of obesity-related conditions, consideration at a BMI of 30 to 34.9 with metabolic disease, and 27.5 as the threshold for Asian individuals. ASMBS states the 1991 NIH criteria no longer reflect best practice. Who supplies it. Your surgeon writes the letter of medical necessity. Your primary care physician supplies weight history and comorbidity records. You supply the plan's criteria document and the timeline. Denial reason: experimental or investigational What it means. The plan classifies the specific operation as unproven. This is rarely applied to sleeve gastrectomy or Roux-en-Y gastric bypass anymore, which have decades of data. It shows up for newer or endoscopic procedures. Anthem, for example, currently lists one anastomosis gastric bypass, SADI, gastric plication, intragastric balloons and transoral outlet reduction as not medically necessary. What rebuts it. Published evidence on safety and effectiveness, plus a letter from your surgeon addressing why this procedure and not another. Professional society positions carry weight, and this category moves. Be realistic too: if the plan will cover a sleeve or a bypass and calls your preferred procedure investigational, the faster path to an operation is often the covered procedure, and that is a conversation to have with your surgeon. Who supplies it. Your surgeon, with literature. You supply persistence. Denial reason: excluded under the plan What it means. The plan says it does not cover this category of service at all, regardless of medical necessity. What rebuts it. First, verify the exclusion actually exists. Pull the plan document and find the language. If you cannot find it, ask the plan to cite the exact section. Denials citing exclusions that are not in the plan document do happen. Second, check the codes. If a covered procedure was submitted under a code the plan treats as non-covered, you will get an exclusion denial for a service that is in fact covered. Ask which CPT and ICD-10 codes were submitted and have your surgeon's office confirm they are correct. Third, if the exclusion is real, see the self-funded section at the end of this article. That is where the leverage is. Denial reason: documentation incomplete What it means. Something was missing. This is the most fixable denial and often the fastest to reverse. What rebuts it. Call and ask precisely which item was missing. Do not accept "additional documentation." Get the item named. Then supply it. Common gaps: a missing psychological clearance, a missing cardiac or pulmonary clearance, a gap in the supervised weight loss months, weight history that does not go back far enough, or a letter of medical necessity that recites your BMI without naming your comorbidities. Who supplies it. Whoever holds the missing record. Usually your primary care physician or the evaluating clinician. Your coordinator can chase it, but you should confirm it was sent. Denial reason: wrong code submitted What it means. A clerical error. The diagnosis code did not support the procedure code, a required BMI code was omitted, or the procedure code was wrong. What rebuts it. A corrected claim, which is faster than an appeal. Medicare, for example, expects a primary diagnosis of E66.01, E66.812 or E66.813, paired with a comorbidity code and a BMI code from Z68.35 to Z68.45. Ask your surgeon's billing office to compare what was submitted against the plan's own policy and resubmit. Who supplies it. The billing office, entirely. Your job is to notice and to ask. Denial reason: did not complete a required supervised diet What it means. Your plan required a defined number of consecutive months of documented supervised weight management, and the record shows a gap or a shortfall. What rebuts it. If the visits happened and the documentation is thin, get the notes. Sign-in sheets, visit summaries and dated weights from those visits can close the gap. If you genuinely missed months, you can still argue the requirement itself. ASMBS has told insurers that requiring documentation of prolonged preoperative diet efforts is inappropriate and counterproductive, given what it calls the complete absence of a reasonable level of medical evidence. Its open letter states there are no studies documenting the efficacy of the approach, cites evidence that mandated preoperative counseling does not improve outcomes and increases dropout, notes that delays aggravate obesity comorbidities, and cites increased mortality among patients evaluated for bariatric surgery who do not undergo it because of insurance denial. Quote it. Attach it. Who supplies it. You attach the society statements. Your surgeon writes the clinical argument that further delay is harmful in your specific case, naming your specific comorbidities. How to write the letter Keep it short. The person reading it may take seconds to decide whether to pursue your appeal. One page. Structure it like this: Your name, member ID, claim or reference number, and date of the denial letter, at the top. One sentence stating what you are appealing. The denial reason quoted from their letter. Three to five numbered points, each answering the reason and naming the enclosure that proves it. A one-line list of enclosures. No life story. No anger. The clinical narrative belongs in your surgeon's letter, and your enclosures do the arguing. Send it by certified mail with return receipt so someone has to sign for it, and keep the receipt. Internal appeal, second level, and external review Internal appeal. You have 180 days from the denial notice to file. The plan must decide within 15 days for a pre-service claim such as a prior authorization, 30 days for a service you have already received, and 72 hours for urgent care. On appeal specifically, plans have 30 days for services not yet received and 60 days for services already received. A different reviewer than the one who denied you must handle it. Second-level internal appeal. Many plans, particularly self-funded ones, offer or require a second internal level before you can go outside. Your denial letter and your plan document say whether yours does. Do not skip a required level, because skipping it can cost you the external review. External review. Once you have a final internal denial, an independent reviewer who does not work for your insurer takes the case, and the insurer is required by law to accept the result. You have four months from the final internal determination to request it. Standard external review must be decided no later than 45 days after the request; expedited review no later than 72 hours. In urgent situations you can request external review without finishing the internal process. One important current caveat. Most states run their own external review process. Alabama, Florida, Georgia, Texas and Wisconsin, plus several territories, use the federal HHS-administered process, and CMS states that as of July 1, 2026 that federal process is temporarily unavailable while HHS works on it. If you live in one of those states, read your denial letter carefully for where to send the request and call the plan to confirm, rather than assuming the federal address still works. Your state may also have a Consumer Assistance Program that will help you file. The name of it is supposed to appear on your denial notice. If your employer self-funds the plan: the move most people never make This is the highest-leverage paragraph in this article. If your employer self-funds, your employer pays the claims and your employer designs the benefit. The insurance company on your card is an administrator. That means the exclusion is your employer's decision, and your employer can remove it. In 2025, 67 percent of covered workers were in self-funded plans, including 80 percent at firms with 200 or more workers. There is a good chance this describes you. How to raise it, in order: Confirm the plan is self-funded. Ask HR directly, or check the Summary Plan Description. Find the benefits manager, not the HR generalist. You want the person who talks to the broker. Send a short written request asking that bariatric surgery be added as a covered benefit at the next plan year. Make it a business case, not a personal plea. Point to the cost of the comorbidities the plan is already paying for, and ask whether the benefit could be added through an accredited center or a centers of excellence network so the employer keeps quality controls on it. Ask whether anyone else has requested it, and ask when renewal is, because benefit changes happen there. This is slow. It will not help you this month. But it is the only path that turns a flat exclusion into coverage, and it has worked for people before you. One last thing. Persistence is the whole game here. You may be on hold a long time, you may get a representative who is rude, and you may get an answer you are certain is wrong. Take a breath and try again the next day. The system is not designed to be easy, and the people who get through it are usually not the ones with the best case. They are the ones who kept calling.

If you have been reading about weight loss surgery for a while, you have probably run into someone who says the duodenal switch is the operation everyone should have had. You have probably also run into someone who says it wrecked their nutrition. Both of those people may be telling the truth about their own experience. This is the operation with the widest gap between what it can deliver and what it demands. How rarely it is done Of 270,089 metabolic and bariatric procedures estimated in the United States in 2023, biliopancreatic diversion with duodenal switch accounted for 3,775, which is 1.4 percent. ASMBS counts SADI-S separately, at 2,387 procedures, which is 0.9 percent. Everything else, one anastomosis gastric bypass, endoscopic sleeve, balloons and other procedures, accounted for 10,501, or 3.9 percent. So the entire duodenal switch family is a small fraction of what surgeons do. That is worth knowing before you go looking for a surgeon, because experience with these operations is concentrated in relatively few centers. What BPD/DS actually is The biliopancreatic diversion was first described by Scopinaro in 1979 and combined a horizontal stomach resection with a rerouting that left a 50 cm common channel. It caused bile gastritis, and was modified into the duodenal switch by DeMeester in 1987. The modern operation has three elements: a sleeve gastrectomy, division of the duodenum just past the pylorus, and construction of an alimentary limb of roughly 200 to 250 cm. The key difference from a gastric bypass is where the digestive juices rejoin the food. In a duodenal switch, that junction is much further down, so the stretch of intestine where fat and fat soluble vitamins can actually be absorbed is short. That is the source of both the power and the cost. Because the pylorus is preserved, gastric emptying stays more physiologic than after a classic biliopancreatic diversion, and dumping syndrome is less of a feature than it is after a Roux-en-Y bypass. What SADI-S changes Single anastomosis duodeno-ileal bypass with sleeve gastrectomy, also called one anastomosis duodenal switch, does the same thing with one intestinal join instead of two. That makes the operation shorter and technically less demanding, and removes one potential leak site and the mesenteric defect that goes with it. The IFSO position paper of 2018 concluded that the procedure is likely to be a safe and efficacious treatment for obesity and its related diseases, while noting that there was insufficient long term data and minimal high level evidence. The 2020 update carries that conclusion forward and calls for registry enrollment and more randomized trials. What the outcome data show A 2025 systematic review and meta-analysis compared SADI-S with Roux-en-Y gastric bypass across 8 studies and 4,259 patients, 1,625 of whom had SADI-S. With a mean follow up of about 3.9 years in the long term subset, SADI-S produced greater total weight loss by a mean difference of 10.03 percentage points, greater excess weight loss by 10.15 percentage points, and higher odds of diabetes remission with an odds ratio of 3.48. Long term complications were not significantly different. In patients with a BMI under 50, SADI-S had fewer short term complications, fewer severe complications and a shorter hospital stay than bypass. For the two anastomosis duodenal switch, the most useful evidence is a randomized trial from Sweden and Norway that enrolled 60 patients with a BMI between 50 and 60 and followed 48 of them for a median of 12 years. Total weight loss was 33.9 percent after duodenal switch against 20.0 percent after gastric bypass. BMI reduction was 20.3 points against 11.0. Lipid profiles improved more after the switch. That is a genuinely large difference and it is the strongest argument for the operation. Now the other side of the same trial. The cost, stated plainly In that same randomized trial: Total adverse events were higher after duodenal switch, 135 against 97 for bypass. More patients developed vitamin deficiencies, 21 against 11, including 25-hydroxyvitamin D deficiency in 19 against 9. Bone mass fell in both groups between 5 and 10 years, and was lower after duodenal switch at 10 years. Four of 29 duodenal switch patients, 14 percent, developed severe protein calorie malnutrition. Three of them, 10 percent, needed revisional surgery for it. The trial authors concluded that BMI reduction was greater after the switch but that gastric bypass had the better risk profile over 10 years, and that the duodenal switch may not be a better surgical strategy than bypass for patients starting at a BMI of 50 to 60. That is a randomized trial saying the more powerful operation was not clearly the better choice in exactly the population it is usually recommended for. You should weigh that. Leak rates are not the differentiator people assume. The incidence of gastric or duodenal leak after duodenal switch has been reported at 1.14 percent, compared with 1.12 percent for gastric bypass, though the leak tends to occur at the duodenal anastomosis. Postoperative bleeding that needs intervention or transfusion is described as uncommon. The monitoring burden The duodenal switch is described as the one bariatric procedure associated with the greatest nutritional and metabolic complications. Common deficiencies include iron deficiency anemia, protein calorie malnutrition, hypocalcemia, and shortfalls in the fat soluble vitamins along with B1, B12 and folate. Every patient starts supplementation immediately after surgery and close follow up with laboratory studies is essential. ASMBS nutritional guidance sets a higher calcium target for BPD/DS patients, 1,800 to 2,400 mg daily, compared with 1,200 to 1,500 mg for sleeve and bypass patients, and a higher vitamin A target for BPD/DS patients, 10,000 IU daily, against 5,000 to 10,000 IU for sleeve and bypass patients. Nutrient screening should be done every 3 to 6 months in the first year and annually after that. In practice, patients with a duodenal switch are usually monitored more often than that and for the rest of their lives. If you cannot see yourself getting blood drawn on a schedule for decades, taking multiple supplements every single day, and calling your team when something looks off, this is not the operation for you. That is not a judgment. It is arithmetic. Who these operations are for The duodenal switch is generally considered for people with a BMI of 50 or higher, or for people whose type 2 diabetes has not responded adequately to other approaches, or as a second stage after a sleeve that has not delivered. It achieves the greatest mean excess weight loss and the highest rates of long term diabetes remission of any bariatric procedure, and for the right person that is decisive. SADI-S is increasingly chosen instead of the two anastomosis version because it is simpler and appears to carry a favorable short term safety profile, but its very long term data are still accumulating. If a surgeon offers you either operation, ask how many they do a year, ask what their follow up protocol looks like at year 5 and year 10, and ask what happens if you develop malnutrition. A surgeon who welcomes those questions is the one you want. The honest summary These are high commitment operations. They deliver more weight loss and better metabolic results than anything else available, and they extract a price in nutritional vigilance that never ends. Anyone who presents them as simply the strongest option without that second half of the sentence is not giving you the full picture.

This one gets confused with dumping constantly, including by clinicians who do not see many bariatric patients. The confusion matters, because the two conditions arrive on different schedules, carry different risks, and are worked up differently. If you have been told for two years that your afternoon shakiness is "just dumping" and it is getting worse rather than better, this is the article to read. How it differs from dumpingThe clearest separator is timing, in two senses. Timing after a meal. Dumping symptoms, in the early form, occur within an hour of eating. Post-bariatric hypoglycemia occurs 1 to 3 hours after eating.Timing after surgery. This is the bigger clue. Dumping tends to show up in the first months and improve. Post-bariatric hypoglycemia typically appears more than a year after surgery, and it can start several years out, in someone who was doing fine.Late dumping and post-bariatric hypoglycemia overlap in mechanism and symptoms, and some clinicians treat them as points on one spectrum. The practical distinction is severity and course. Late dumping is uncomfortable and tied tightly to sugary meals. Post-bariatric hypoglycemia can produce genuine neuroglycopenia, meaning glucose low enough that the brain stops working properly, and it can happen after meals that did not look like a trigger. The mechanismAfter a bypass, food reaches the small intestine fast. That triggers an outsized release of incretin hormones, principally GLP-1 and GIP. Those hormones tell the pancreas to release insulin, and the insulin response is both larger and later than the glucose load requires. By the time insulin peaks, the glucose is gone, and blood sugar falls below where it started. The central role of GLP-1 has been demonstrated directly: continuous infusion of a GLP-1 receptor antagonist reduces the meal-induced insulin response in patients who have had a bypass. Improved insulin sensitivity after major weight loss, and changes in glucagon and ghrelin signaling, add to the effect. This is also why the condition is associated with the malabsorptive operations rather than purely restrictive ones, though it is reported after sleeve gastrectomy as well. How common it isReported figures range from about 10 percent to 72 percent, and the range is that wide because the definitions and testing methods differ enormously. Some anchors from studies that opened this up: After Roux-en-Y gastric bypass, one dataset showed reactive hypoglycemia rising from 0.5 percent before surgery to 9.1 percent at 12 months, easing slightly to 7.9 percent at 60 months.After sleeve gastrectomy, about 14 percent of patients reported reactive hypoglycemia at one year.Studies using oral glucose tolerance testing report between 9.1 percent and 32.8 percent.A 2022 meta-analysis using continuous glucose monitoring found low readings in more than half of post-bariatric patients, which almost certainly overstates the true rate because continuous monitors generate false lows.A Swedish registry cohort found clinically coded hypoglycemia in only about 0.2 percent of bypass patients without diabetes, against 0.04 percent in the general population, and a retrospective cohort of more than 6,000 patients at a single center reported a rate of 1.4 percent.Read that spread the way it should be read. Occasional symptomatic dips are common. Hypoglycemia severe and persistent enough to require medical management is uncommon. Both statements are true and neither one should be used to dismiss you. Recognizing itAdrenergic symptoms come first: palpitations, shakiness, sweating, anxiety, irritability, dizziness and sudden hunger. If glucose keeps falling, neuroglycopenic symptoms follow: confusion, slurred speech, blurred vision, difficulty concentrating, and in severe cases seizure or loss of consciousness. The pattern to notice is that the episodes cluster 1 to 3 hours after eating, are worse after carbohydrate-heavy meals eaten without protein, and resolve when you eat something. The driving problemThis deserves its own paragraph because people minimize it. Severe hypoglycemia causes motor vehicle accidents, falls, and deaths. An episode of neuroglycopenia while driving is a genuine emergency, and many people with this condition have had at least one near miss before they took the diagnosis seriously. Until you have this characterized and controlled, treat driving as something to plan around rather than something to hope about. Ask your clinician what checking before you drive should look like for you. Keep fast-acting glucose within reach in the car, not in the trunk. Tell someone you live or work with what the symptoms look like from the outside, because you may not recognize them yourself once glucose is low enough. And raise it with your clinician, who may have reporting obligations in your state and will certainly have an opinion. Getting it diagnosed properlyThe diagnostic standard is Whipple's triad: symptoms consistent with hypoglycemia, a documented low glucose at the time of the symptoms, and resolution of symptoms when glucose is corrected. All three parts matter. Symptoms alone are not enough, and a low reading on a home meter without symptoms is not enough either. Severity is graded roughly as mild at 54 to 70 mg/dL, moderate at 40 to 54 mg/dL, and severe at or below 40 mg/dL. Practical workup usually starts with home fingerstick readings taken during episodes, paired with a food diary. From there: Mixed meal tolerance testing is the more useful provocative test, because it reproduces what actually happens when you eat.Oral glucose tolerance testing is less reliable after a bypass and can provoke severe symptoms. It is falling out of favor for this indication.Continuous glucose monitoring is increasingly used, and newer sensors are more accurate than older generations. Over-the-counter monitors are now available in the United States. Interpret them with a clinician, because false lows are common and a scary graph is not a diagnosis.Your clinician will also want to rule out the other causes of low blood sugar, including insulin or sulfonylurea use, adrenal insufficiency, and, rarely, an insulinoma. Managing itDiet is the foundation and it works for most people. Small, frequent, nutrient-dense meals rather than three large ones.Carbohydrate limited to roughly 15 to 30 grams per meal, chosen from low glycemic index sources.Protein and fat with every carbohydrate serving. Never a carbohydrate on its own.No liquids with meals.Avoid sugary drinks entirely, including juice, except as treatment for an active episode.Uncooked cornstarch, which releases glucose slowly, has shown promise for overnight and between-meal coverage.There is no medication approved by the FDA for post-bariatric hypoglycemia. Everything used is off-label: acarbose, diazoxide, calcium channel blockers such as nifedipine or verapamil, somatostatin analogues, SGLT2 inhibitors, and GLP-1 receptor antagonists such as avexitide, which has been studied in trials specifically for this condition. Surgical reversal of the anatomy is a last resort. When to get specialist careAsk your surgeon for a referral to an endocrinologist with bariatric experience if any of these apply: you have had an episode with confusion, seizure or loss of consciousness; you have had episodes while driving; you cannot control symptoms with dietary changes after a genuine trial of them; you are avoiding meals or living on constant snacking to stay ahead of it; or someone has proposed starting a medication for it. That last one is not a dietary decision and it should not be made without testing that establishes what is actually happening to your glucose.

People think approval is a decision someone makes about whether you deserve surgery. It is not. It is a clerk or a nurse reviewer checking whether a stack of paper contains specific items. If an item is missing, the answer is no, and the reason on the letter will not tell you which item was missing unless you ask. Understanding the packet is how you stop being a passenger in this process. Who assembles it Your surgeon's office does. Most bariatric programs have an insurance coordinator or a prior authorization specialist whose entire job is this. Find out that person's name and direct phone number at your first visit and write it down. They are the single most useful contact you will have for the next six months. But the coordinator can only submit what exists. They cannot conjure five years of documented weight history out of a chart that does not have it, and they cannot attend your nutrition visits for you. The parts that depend on you are the parts that stall. What a prior authorization request actually contains Payer medical policies are public, and they tell you exactly what the reviewer is looking for. Anthem's clinical guideline for bariatric surgery requires all of the following for an initial operation: age 18 or older; an approved procedure; a BMI of 40 or higher, or 35 or higher with an obesity-related comorbidity such as diabetes, cardiovascular disease, hypertension, severe cardiopulmonary problems, or liver disease; documented past participation in a weight loss program; documented inadequate weight loss despite a committed attempt at conservative medical therapy; preoperative medical and mental health evaluations and clearances; preoperative education covering risks, benefits, realistic expectations and the need for long-term follow-up; and a treatment plan addressing pre- and post-operative needs. Aetna's published policy bulletin is stricter on one point. It requires documented participation in an intensive multicomponent behavioral intervention consisting of 12 or more sessions on separate dates within the two years before surgery. Your plan will differ from both. Get your plan's medical policy document and read the criteria list as a checklist. Documented BMI history Payers want to see that your obesity is longstanding, not a recent development. That means dated height and weight measurements in a medical record, usually from your primary care physician, usually going back two to five years. Chart notes count. Your own records do not. If your primary care records are thin, start now. Ask your PCP's office to send the bariatric program your last several years of visit notes. If you have moved or changed doctors, request records from the old practice in writing. This is the item that most often delays a packet by months, and it is the one you can start fixing today. Comorbidity documentation A comorbidity is not established by you saying you have it. It has to be documented with the diagnosis and, where relevant, objective testing. Sleep apnea needs a sleep study. Diabetes needs labs. Hypertension needs recorded readings and usually a medication list. If you have been told you snore badly and have never had a sleep study, get one, because untreated sleep apnea both strengthens your case and matters for your anesthesia safety. Psychological evaluation Nearly every payer requires it, and a lot of people dread it. That dread is usually misplaced. The evaluation is not someone deciding whether you are crazy. It is a structured interview and often a questionnaire, checking that you understand what the operation does, that you can follow a demanding post-op regimen, that eating patterns like binge eating or purging are identified and addressed, and that any untreated psychiatric illness or active substance use is caught before an operation rather than after. Being honest gets you a better plan. Being evasive gets you a deferral and a second appointment. Nutrition visits These serve two purposes at once: they are frequently a coverage requirement, and they are how you learn the post-op eating protocol before you are recovering from surgery and trying to learn it. Go to all of them. Keep the appointment slips. Medically supervised weight loss, where it is still required Some plans still require three, six or twelve consecutive months of documented physician-supervised weight management before they will approve surgery. This requirement is under sustained attack and you should know that when you are in it. ASMBS has told insurers that requiring documentation of prolonged preoperative diet efforts before approval is inappropriate and counterproductive, given what it calls the complete absence of a reasonable level of medical evidence for the practice. Its open letter states there are no studies documenting the efficacy of the approach, citing evidence that mandated preoperative counseling does not improve outcomes and increases dropout, that there is no benefit in long-term weight loss or compliance, that delays aggravate obesity comorbidities, and that mortality is increased in patients evaluated for bariatric surgery who do not undergo it because of insurance denial. None of that gets you out of the requirement if your plan has it. What it gets you is language for an appeal, and a reason to check whether your plan's requirement is current rather than assuming the coordinator's memory of it is. The operational rule while you are in a supervised program is not to miss a month. A gap in consecutive months restarts the clock on many plans. Schedule the next visit before you leave the current one. Codes The packet carries diagnosis and procedure codes, and a wrong code produces a denial that has nothing to do with your medical facts. For Medicare, the supporting diagnosis is E66.01 for morbid obesity, or E66.812 or E66.813 for class 2 and class 3 obesity, paired with a BMI code in the Z68.35 to Z68.45 range and a comorbidity code. Common procedure codes include 43775 for laparoscopic sleeve gastrectomy and 43644 for laparoscopic Roux-en-Y gastric bypass. You do not need to be an expert. You need to be able to ask your coordinator which codes were submitted and to write them down, because if you are denied, that is the first thing to check. Realistic timelines Two separate clocks run, and people confuse them. The first clock is you gathering documentation. If your plan requires six months of supervised weight loss, that is six months, plus the time to get records, the psych eval and the clearances. Programs commonly quote three to six months, and a year is not unusual when records have to be chased. The second clock is the plan's decision, and it is short. A pre-service claim, which is what a prior authorization is, must be decided within 15 days under the federal claims rules for ERISA plans, with one 15-day extension allowed when circumstances outside the plan's control prevent a decision. HealthCare.gov states the same 15-day standard for prior authorization requests. If your request has been sitting for a month, something is wrong. Call and find out what. Certified mail, and your own copy of everything If you are sending anything yourself, send it by certified mail with return receipt so that someone at the insurance company has to sign for delivery. Proof of delivery ends the argument about whether they got it. Keep your own complete copy of the packet. Not the coordinator's copy. Yours. That means: The full prior authorization submission, including the letter of medical necessity and the codes. Every clearance letter. Your weight history documentation. Sign-in sheets or visit summaries from every nutrition and supervised weight loss appointment. Every letter the plan sends you, including the envelope. A call log with dates, names and reference numbers. Scan it or photograph it and keep a copy somewhere that is not your house. If you are denied, this folder is your appeal. If you are approved, it is what you need if the claim is later processed wrong. Building it costs you an hour a month. Rebuilding it after the fact can cost you a year.

People often describe the bypass as the drastic one. The word doing the work there is usually fear rather than data. The bypass is a well studied operation with the best evidence base of any procedure for two specific problems: type 2 diabetes and reflux. It also asks more of you afterward than a sleeve does, permanently, and you should decide with that fully in view. The anatomy, in plain terms Roux-en-Y gastric bypass has three parts. The pouch. The surgeon staples off a small pouch at the top of your stomach, separate from the rest. The remainder of your stomach stays in place but food no longer passes through it. The biliopancreatic limb. This is the duodenum and the first stretch of jejunum, which stay connected to the remnant stomach and carry digestive juices from your stomach, liver and pancreas. It is typically measured about 50 to 75 cm from the ligament of Treitz and then divided. The Roux limb. This is the stretch of jejunum brought up and joined directly to the pouch, usually measured 100 to 150 cm with an average around 120 cm. Food travels down this limb. The biliopancreatic limb is then joined back to the intestine further down, so digestive juices and food finally mix at that junction. NIDDK describes the net effect as food bypassing most of the stomach and the upper small intestine, so fewer calories are absorbed, alongside changes to the hormones and bacteria in the gut that affect appetite and metabolism. Why it works on three levers at once The pouch restricts how much you can eat at a sitting. The rerouting produces a strong hormonal shift, since food now reaches the lower intestine faster and in a less digested state, which changes incretin signaling and does a great deal of the work on blood sugar. And because food and digestive enzymes do not meet until partway down, there is a genuine, if modest, malabsorptive component. That combination is why the bypass acts on diabetes faster and more completely than restriction alone ever does. The operation and the recovery The bypass is performed laparoscopically or robotically. Steps are pouch creation, biliopancreatic limb creation, the jejunojejunostomy joining the two limbs, and the gastrojejunostomy joining the Roux limb to the pouch. A leak test is performed before closing. Robotic and laparoscopic approaches have shown similar safety and efficacy, with longer operative times for robotic cases. An overnight stay is standard, and with enhanced recovery protocols many people go home within two to three days. Same day discharge has been linked to increased morbidity and most centers avoid it. On safety, ASMBS puts the overall risk of major complications after metabolic and bariatric surgery at about 4 percent and death at about 0.1 percent. Bypass specifically carries a mortality of roughly 0.2 percent, higher than sleeve or band. Anastomotic or staple line leak rates after bypass are reported between 0.4 percent and 5.2 percent, most often at the gastrojejunostomy. If you have read older patient material quoting leak rates in the teens, that material is out of date. What weight loss looks like Patients typically experience 60 to 70 percent excess body weight loss, with sustained results in long term studies. In SLEEVEPASS at 10 years, median excess weight loss after bypass was 50.7 percent, compared with 43.5 percent after sleeve. In a separate randomized trial of patients starting at a BMI of 50 to 60, total weight loss at a median of 12 years was 20.0 percent after bypass. Two useful things fall out of those numbers. The bypass outperforms the sleeve on weight, but not by an enormous margin. And people starting at a very high BMI lose a smaller proportion of their total weight than the headline figures suggest. Set your expectations against your own starting point. Where the bypass genuinely pulls ahead Type 2 diabetes The ARMMS-T2D pooled analysis of four randomized trials followed 262 participants for a median of 11 years. The surgical arm included sleeve gastrectomy and gastric banding as well as bypass, so read it as evidence for surgery rather than for bypass alone. At 7 years, hemoglobin A1c fell by 1.6 percent in the surgery group from a baseline of 8.7 percent, compared with a 0.2 percent change in the medical and lifestyle group. Diabetes remission at 7 years was 18.2 percent after surgery against 6.2 percent with medical management, and at 12 years it was 12.7 percent against zero. Surgery patients used fewer diabetes medications throughout. Notably, 25 percent of the medical group went on to have surgery anyway during follow up. Those remission numbers are lower than the ones you see in marketing material, and they are more honest. Long term remission is a minority outcome. Better glycemic control on fewer drugs is the common outcome, and it is worth a great deal. In SLEEVEPASS specifically, diabetes remission at 10 years was 33 percent after bypass and 26 percent after sleeve, a difference that was not statistically significant in that trial. Reflux This is the clearest advantage. At 10 years in SLEEVEPASS, esophagitis was present in 7 percent of bypass patients compared with 31 percent of sleeve patients, and 36 percent were on proton pump inhibitors compared with 64 percent. If you already have GERD before surgery, gastric bypass frequently reduces or eliminates symptoms. Part of that is anatomical, since acid produced in the remnant stomach no longer has a path up to your esophagus. Part of it is behavioral, since you eat smaller meals, eat more slowly, and the post operative diet limits fatty food, alcohol and caffeine. This is also why the bypass is the destination for most sleeve revisions. Among conversions from sleeve to bypass recorded in the MBSAQIP database in 2020 and 2021, GERD was the indication in 55.3 percent of cases. What the bypass asks of you, permanently Supplementation for life Because you are bypassing the duodenum and part of the jejunum, absorption of iron, calcium and B vitamins is reduced. ASMBS nutritional guidance for bypass patients includes at least 12 mg of thiamine daily, 45 to 60 mg of elemental iron daily, 400 to 800 micrograms of folate daily, 1,200 to 1,500 mg of calcium daily, and 3,000 IU of vitamin D3 daily until blood levels are sufficient, plus B12 replacement. Nutrient screening should happen every 3 to 6 months in the first year and annually after that. This is not optional and it does not stop after five years. No NSAIDs Marginal ulcers, ulcerations at the join between pouch and intestine, occur in roughly 4.6 percent of bypass patients. Nonsteroidal anti-inflammatory drugs are a well established risk factor, along with smoking, alcohol, Helicobacter pylori infection and immunosuppression. That means ibuprofen, naproxen and aspirin come off your list unless your surgeon specifically clears them. Ask about alternatives before you need them, not at two in the morning with a headache. Dumping syndrome Because the pylorus is bypassed, food can pass rapidly into the small intestine. Early dumping happens 10 to 30 minutes after eating and produces nausea, cramping, diarrhea and flushing. Late dumping happens 1 to 3 hours after eating and is reactive hypoglycemia, showing up as sweating, weakness, dizziness and palpitations. Management is mostly dietary, meaning smaller and more frequent meals and avoiding sugar heavy foods, with medication reserved for stubborn late dumping. Some people find dumping useful as a feedback mechanism. Most find it unpleasant. Neither reaction is wrong. Other things worth knowing Internal hernia is a real long term risk because of the mesenteric defects created during surgery. New, severe or crampy abdominal pain after a bypass is not something to sit on. Call your surgeon. Gastrogastric fistula, an abnormal connection between pouch and remnant stomach, occurs in an estimated 1 to 6 percent of divided bypasses. NIDDK notes that bypass may increase the risk of alcohol use disorder. Take that seriously if alcohol has ever been a difficult subject for you. Reversal is possible but difficult, and is done only if medically necessary. Who the bypass suits It is often the right operation if you have type 2 diabetes, if you have significant reflux or a hiatal hernia, if you have Barrett's esophagus, or if you have already had a sleeve that is not holding. It suits people who are willing to take supplements and get labs drawn for the rest of their lives. If that commitment sounds unrealistic when you are honest with yourself, say so during your evaluation rather than after.

Dumping syndrome has a reputation problem. People arrive at surgery either terrified of it or vaguely hoping for it as a built-in punishment system for eating badly. Neither view is quite right. It is a real physiological event with a real mechanism, it is more common after some operations than others, it is largely controllable with food choices, and for most people it fades. What is actually happeningNormally your stomach releases food into the small intestine slowly, in a controlled trickle, with the pylorus acting as a valve. After a gastric bypass the pylorus is bypassed entirely. After a sleeve, the stomach is a narrow tube that empties faster than it used to. So food arrives in the small intestine quickly and largely undigested. If that food is high in sugar, it is osmotically active, and it pulls water out of the bloodstream into the intestine. That fluid shift is what causes the cramping, the bloating and the diarrhea, and it contributes to the drop in blood pressure that makes you feel faint. At the same time, the sudden arrival of nutrients in the small intestine triggers a large release of gut hormones, including GLP-1, which drives sympathetic activation and a surge of insulin. Those two consequences, the fluid shift and the hormone surge, happen on different timelines. That is why dumping comes in two forms. Early dumpingEarly dumping starts during a meal or within about an hour of finishing one. The symptoms come in two clusters. Gut symptoms: nausea, vomiting, cramping, bloating, an unexpected feeling of overfullness, and diarrhea.Circulatory symptoms: a racing heart, flushing, sweating, lightheadedness, and in some people frank fainting.It is unpleasant and it can be frightening the first time, particularly the heart rate. It is generally not dangerous in itself, though the faintness is a real hazard if you are standing on a stair or driving. Late dumpingLate dumping arrives one to three hours after a meal and is driven by the insulin surge, not the fluid shift. By the time the insulin peaks, the sugar that triggered it has already been absorbed and cleared, so blood glucose overshoots downward. The symptoms are the symptoms of low blood sugar: sweating, shakiness, palpitations, weakness, sudden hunger, difficulty concentrating and confusion. Late dumping sits on a spectrum with post-bariatric hypoglycemia, which is covered separately because it behaves differently, tends to appear much later after surgery, and needs a different workup. If your low-blood-sugar episodes started a year or more after your operation, or if they are severe enough to make you feel unsafe, treat that as its own problem rather than as dumping. How common it is, and after which operationsThe honest answer is that the reported numbers are all over the place, and the reason is that the number depends entirely on how you ask. Symptom questionnaires catch far more people than physiological testing does, and questionnaires that ask about symptoms in general catch more than questionnaires that ask about symptoms clearly tied to eating. A systematic review of dumping after bariatric surgery reported early dumping in about 9.4 percent of gastric bypass patients and late dumping in about 6.6 percent, while noting that rates in the underlying studies run as high as 76 percent depending on how dumping was defined and measured.The same review found sleeve gastrectomy generally produced lower rates, though some sleeve studies reported early dumping in roughly 24 to 41 percent of patients, and some found late dumping rates that were not lower than bypass at all.A clinical review of post-bariatric medical management put the figure at up to 20 percent in large survey studies and up to 40 percent in smaller prospective ones.One-anastomosis gastric bypass has been reported with dumping in around 43 percent of patients.Two safe conclusions come out of that mess. Dumping is common enough after bypass that you should plan for it. And it happens after sleeve gastrectomy too, which surprises people who were told the sleeve does not cause it. Managing it with foodDiet is the first-line treatment and for most people it is the only treatment needed. The changes are specific rather than vague. Cut concentrated sugar. This is the single highest-yield change. Sugary drinks, fruit juice, sweetened coffee, desserts, and anything where sugar arrives without much protein, fat or fiber alongside it.Watch for hidden sugar. Sauces, flavored yogurts, protein bars, breakfast cereals, and some liquid medications. If a liquid medicine is available in a low-sugar form, ask for that one.Separate liquids from meals. Do not drink with food, and wait about 30 minutes after eating. Liquid speeds gastric emptying, which is exactly what you are trying not to do.Eat smaller meals, more often. Six small feedings rather than three larger ones.Pair carbohydrate with protein and fat. Both slow transit and blunt the glucose spike.Slow down. Eating quickly delivers a larger bolus to the intestine at once.Lie down for about 30 minutes after eating if the faintness is the worst part. It helps with the blood pressure drop specifically.Viscosity agents such as pectin or guar gum, which thicken stomach contents and slow emptying, are sometimes used. For people whose symptoms do not respond to diet, acarbose is used for late dumping because it slows carbohydrate absorption, and somatostatin analogues such as octreotide or lanreotide are used for both forms because they slow transit and blunt the hormone release. Surgical revision for dumping is rare and reserved for refractory cases. All of these are decisions for your surgeon or a bariatric-literate gastroenterologist, not for a forum thread. Does it go awayLargely, yes, and there is a pattern to it. Early dumping tends to peak somewhere in the first 6 to 12 months and then decline. As it declines, some people see late dumping appear for the first time, which reviewers describe as a prevalence switch driven by the gut adapting: glucose transporters increase, absorption gets faster, and the insulin response becomes exaggerated. The honest caveat is that not everyone escapes it. Roughly one in five gastric bypass patients reports a lasting reduction in quality of life from dumping. If you are in that group after a year of careful eating, that is a reason to be seen rather than a reason to accept it. The feedback loop questionA lot of people on this site describe dumping as useful. They ate half a candy bar in month four, felt terrible for an hour, and never did it again. That is a real experience and there is no reason to talk anyone out of it. A consequence that arrives 20 minutes after the behavior is a far more effective teacher than a consequence that arrives on the scale six weeks later. What the evidence does not support is treating dumping as part of how the surgery works. Studies that looked for a relationship between dumping and the amount of weight lost have not found a meaningful one. Dumping is not a mechanism of weight loss, and you are not doing worse if you never get it. Late dumping, in particular, can push in the wrong direction: the hypoglycemia produces real hunger, and people eat in response to it. Use the feedback if you get it. Do not go looking for it, and do not read its absence as a sign that your operation is not working.

The most useful thing you can learn this week is not whether bariatric surgery is generally covered. It is whether it is covered under your specific plan, and who has the authority to change that answer. Two people working at the same company, both holding cards with the same insurance logo, can get opposite answers. That is not a mistake. It is how the system is built. Fully insured versus self-funded, and why it decides everything There are two ways an employer can provide health coverage. In a fully insured plan, the employer pays premiums to an insurance company, and the insurance company takes the financial risk and pays the claims. The plan is a product the insurer designed and sold. It is regulated by your state's insurance department, and it has to meet state benefit mandates. In a self-funded plan, the employer pays claims out of its own money and hires an insurance company only to administer the plan. Your card still says Aetna or Cigna or Blue Cross, and the customer service line still answers, but the money is your employer's. These plans are governed by the federal ERISA statute and are generally not subject to state benefit mandates. This matters enormously and almost nobody explains it to patients. Self-funded is the norm, not the exception. The 2025 KFF employer survey found that 67 percent of covered workers are in self-funded plans, including 80 percent of workers at large firms. Here is the part worth remembering: if your plan is self-funded and it excludes bariatric surgery, no state mandate will save you, but your employer can add the benefit. There is a human being at your company who can change the answer. Under a fully insured plan, no one at your company can. The two documents you need, and they are not the same Fully insured plans give you a Summary of Benefits and Coverage. It is the standardized comparison document, and every plan has to give you one. It is short and it is designed for apples-to-apples comparison of price and benefits. You can request one from the insurer at any time. Self-funded employer plans give you a Summary Plan Description. This is the ERISA document. It describes how the plan works, what is covered, what the claims procedures are, and what your rights are. If you do not have one, you have the right to request a free copy from the plan administrator, which is usually your HR or benefits department. The Summary of Benefits and Coverage will often not answer your question. It is too short. The Summary Plan Description, or the full plan document behind it, is where the real answer lives. Ask for the full document, not the summary, and ask in writing. Where the bariatric exclusion hides It is almost never under a heading that says bariatric surgery. Search the document for these, in this order: The exclusions section. Sometimes titled "What Is Not Covered," "General Exclusions," or "Expenses Covered or Not Covered." This is where a flat exclusion lives, and it is often a single line inside a list of forty items. Obesity, weight loss, weight reduction, morbid obesity. Search all of these words. Plans are inconsistent about which one they use. The medical policy or clinical criteria referenced by the plan. Even when surgery is covered, the criteria that decide your case usually live in a separate medical policy document that the plan incorporates by reference. Ask for it by name. Limitations. A one-lifetime-procedure limit or a waiting period after enrollment usually appears here rather than in exclusions. If you find nothing, that does not mean it is covered. It means you have to ask. The exact question to ask on the phone This is the single most valuable sentence in this article. Do not ask "is bariatric surgery covered." Ask: "Is bariatric surgery covered under my plan when it is medically necessary?" Some representatives will answer no to the first question and yes to the second, because in their system the surgery is not covered as an elective benefit but is covered when medical necessity criteria are met. You will be told the wrong thing if you ask the wrong way. Then keep going: Is my plan fully insured or self-funded? What are the medical necessity criteria, and can you send me the medical policy document? Does the plan require prior authorization? Is there a required supervised weight management program, and if so how many visits and over how many months? Is there a lifetime limit on bariatric procedures? Is there a waiting period from my enrollment date? Which procedure codes are covered? Ask about sleeve gastrectomy, Roux-en-Y gastric bypass, and duodenal switch by name. Is this specific surgeon in network? Is this specific hospital in network? Is the anesthesia group at that hospital in network? Be patient and persistent. You might be on hold for a long time, you might get someone who is short with you, and you might get an answer you are sure is wrong. Take a breath and call back. A second representative frequently gives a different and better answer than the first. Get it in writing A verbal yes is worth nothing when the claim is denied. Every time you call, write down the date, the time, the representative's name, and a reference or call number. Then ask them to send you the answer in writing or by secure message through the member portal. If they will not, send them a message through the portal summarizing what you were told and asking them to confirm. Now you have a record with a timestamp. Marketplace and state-by-state variation If you buy your own coverage, the picture changes again. Marketplace plans must cover ten categories of essential health benefits, but bariatric surgery is not one of the named categories. HealthCare.gov states plainly that the specific services covered within each broad benefit category can vary based on your state's requirements. Each state selects a benchmark plan that defines what its essential health benefits actually include, which is why bariatric coverage on the individual market genuinely differs from one state to the next. The practical consequence: do not rely on what someone in another state tells you their marketplace plan covered. Pull the Summary of Benefits and Coverage for the exact plan you are considering, before you enroll, and search it for the exclusion language above. Open enrollment is the one moment you have real leverage, because switching plans is easier than overturning an exclusion. If you find a flat exclusion You have four honest options and it is worth knowing them now rather than after a denial. If the plan is self-funded, ask your employer to add the benefit, because the exclusion is your employer's decision to make. Change plans at open enrollment, if your household has another option. Appeal anyway if you believe the exclusion is being applied to the wrong code or the wrong diagnosis. Self-pay. None of them are fast. All of them are better than assuming the first no was final.

You have probably been told the sleeve is the simple one. That is half true. It is technically simpler than the bypass and it asks less of you afterward. It is also permanent, and it has one weakness that gets glossed over in consultations more often than it should. What is removed and what is left In a sleeve gastrectomy, the surgeon removes roughly 80 percent of your stomach along the greater curvature and leaves a narrow tube, often described as banana shaped, running from your esophagus down to the pylorus. NIDDK describes it as removing most of the stomach and closing the remainder with staples. The pylorus, the valve at the bottom of the stomach, stays. So does the whole of your intestine. Nothing is rerouted. That last point matters more than it sounds. Because food still travels the normal path, you do not get the intestinal malabsorption that comes with a bypass, and you are less likely to run into the specific problems that rerouting causes. Why your hunger changes, not just your capacity The part of the stomach that gets removed includes the fundus, which is where most of your ghrelin is produced. Ghrelin is a 28 amino acid peptide, discovered in 1999, that drives appetite. Plasma ghrelin falls significantly after sleeve gastrectomy, and in one series that fall tracked with weight loss over the first three months before plateauing at six months while weight loss continued. Three mechanisms are usually described for the sleeve: reduced capacity, loss of the fundus so the stomach no longer relaxes to accommodate a large meal, and the hormonal shift involving lower ghrelin along with changes in GLP-1 and PYY. This is why most people report that they are not just physically limited but genuinely less interested in food, at least for the first year or two. The operation itself The sleeve is done laparoscopically or robotically through several small incisions. A calibrating tube, called a bougie and typically sized between 32 and 40 French, is passed into the stomach to size the sleeve. The surgeon separates the stomach from the omentum, exposes the angle of His, and staples along the bougie starting 2 to 6 cm above the pylorus, depending on the surgeon. An international consensus recommended starting at least 3 cm from the pylorus and using a larger bougie, since a 2013 meta-analysis found a 66 percent reduction in leak rate with a bougie of 40 French or larger without a meaningful loss of weight loss effect. Before stapling, your surgeon should look at your diaphragm to see whether you have a hiatal hernia, and repair it if you do. Ask whether this is part of the plan. It is one of the few things that changes your reflux outlook and it is easier to do at the time of your sleeve than later. Most people stay overnight. How long you stay varies by program and by whether your center uses an enhanced recovery protocol. Ask yours what to expect. How much weight, and how fast ASMBS states that people having metabolic and bariatric surgery may lose as much as 77 percent of their excess weight in the first year, depending on the procedure. That is a figure for surgery in general, not a sleeve specific forecast. Treat it as a ceiling. The honest long term picture: In the SLEEVEPASS randomized trial at 10 years, median excess weight loss after sleeve was 43.5 percent, compared with 50.7 percent after gastric bypass, a difference of 8.4 percentage points. In a review of 11 studies covering 1,020 patients followed 10 years or more, mean total weight loss was 24.4 percent, with individual studies ranging from 17 percent to 36.9 percent. Eighty percent of those studies reported more than 20 percent total weight loss maintained. Total weight loss of roughly a quarter of your starting body weight, held for a decade, is a real and useful result. If you started at 300 pounds that is around 75 pounds still gone at 10 years. It is also not the number most people picture when they book surgery. The spread between studies, 17 percent to nearly 37 percent, is wide enough that anyone quoting you a single figure is guessing. In the same long term review, remission rates were 45.6 percent for type 2 diabetes, ranging from zero to 94.7 percent across studies, and 41.4 percent for hypertension, ranging from 14 to 78.4 percent. The variation is genuine and reflects different populations and different definitions of remission. Regain and revision In that 10 year review, 19.2 percent of sleeve patients went on to a further operation, with individual study rates from 1 percent to 49.5 percent. Of those revisions, 67.2 percent were conversions to Roux-en-Y gastric bypass, 19.7 percent to duodenal switch, 6.6 percent to one anastomosis gastric bypass and 5.5 percent to SADI-S. In the SLEEVEPASS trial the overall 10 year reoperation rate was 15.7 percent after sleeve, which was not significantly different from the 18.5 percent seen after bypass. So roughly one in five sleeve patients has another operation within a decade. That is not a failure of the procedure and it is not a failure of yours if it happens to you. It is a known part of the arc. The reflux problem This is the sleeve's specific weakness and the evidence is genuinely contested. Reported rates of new reflux after sleeve range from roughly a third of patients to more than half, depending on how it is measured and for how long. A meta-analysis of nine studies found the odds of GERD were 3.61 times higher after sleeve, and pooled the rate of new onset GERD at 50.8 percent. Pooled erosive esophagitis was 23.1 percent for Los Angeles class A, 14.6 percent for class B, 4.3 percent for class C and 3.3 percent for class D. Pooled Barrett's esophagus was 7.3 percent. The 10 year review put new onset GERD at 32.3 percent, with a range of 21.4 to 58.4 percent, and Barrett's at 0.5 percent. In SLEEVEPASS at 10 years, 31 percent of sleeve patients had esophagitis on endoscopy compared with 7 percent after bypass, and 64 percent were on proton pump inhibitors compared with 36 percent. Barrett's esophagus was found in 4 percent of both groups, with no statistically significant difference. The spread is explained by how the studies defined reflux. Symptom questionnaires and endoscopic findings do not agree with each other, and studies that scoped everyone find more disease than studies that waited for complaints. What is not in dispute is that reflux after sleeve is common, that it is more common than after bypass, and that it is now the leading reason sleeve patients get converted to a bypass later. If you already have significant reflux, a hiatal hernia, esophagitis or Barrett's, raise it before you consent to a sleeve. That conversation belongs with your surgeon. The other thing to be clear about The sleeve cannot be reversed. The removed portion of your stomach is gone. It can be converted to a bypass or a duodenal switch, but you cannot be put back the way you were. If reversibility is important to you, say so out loud during your consultation rather than assuming it is on the table. Nutrition after a sleeve You still need supplements. ASMBS nutritional guidance recommends at least 12 mg of thiamine daily, 45 to 60 mg of elemental iron daily for sleeve patients and menstruating women, 1,200 to 1,500 mg of calcium daily, and 3,000 IU of vitamin D3 daily until blood levels are sufficient. Nutrient labs should be checked every 3 to 6 months in the first year and annually after that. Your program will set your specific regimen. Who the sleeve suits It is a reasonable default for most people who want a durable operation without intestinal rerouting, who do not have significant reflux, and who want a lower supplementation burden than the bypass carries. It is a poor fit if reflux is already part of your life. Bring your heartburn history to the table honestly, even the part where you have been quietly taking antacids for years.